Back

Antisense oligonucleotide targeting pathogenic sense repeat RNA in C9ORF72 suppresses production of antisense-dependent dipeptide repeat proteins implicated in ALS/FTD

Gu, Y.; Kankel, M. W.; Watts, J.; Jafar-nejad, P.; Almeida, S.

2024-10-05 neuroscience
10.1101/2024.10.04.616663 bioRxiv
Show abstract

A six nucleotide repeat expansion in intron-1 of the C9ORF72 gene is the most common genetic mutation affecting individuals with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Bi-directional transcription of the repeat expansion generates sense and antisense repeat RNAs that can then be translated in all reading frames to produce six distinct dipeptide repeat (DPR) proteins with unique termini. The precise site of translation initiation of these proteins within the C9ORF72 repeat expansion remains elusive. We used CRISPR-Cas9 genome editing and steric-blocking antisense oligonucleotides (ASOs) to investigate the contribution of different AUG codons in the antisense repeat RNA to the production of DPR proteins, poly(GP) and poly(PR) in C9ORF72 expansion carrier motor neurons and lymphoblast cells. We then utilized ASOs targeting C9ORF72 sense repeat RNA to examine whether sense or antisense RNA is the major source of the poly(GP) protein - a question for which conflicting evidence exists. We found that these ASOs reduced the intended sense RNA target, but also the antisense RNA, thus preventing the production of poly(PR). Our data highlights the importance of the sequences preceding the antisense CCCCGG repeat expansion for the synthesis of antisense DPR proteins and supports the use of sense C9ORF72 ASOs to prevent the accumulation of both sense- and antisense-dependent DPR proteins in C9ORF72 ALS/FTD.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Molecular Therapy Nucleic Acids
39 papers in training set
Top 0.1%
31.0%
2
RNA
189 papers in training set
Top 0.2%
9.6%
3
Nature Communications
5641 papers in training set
Top 21%
7.9%
4
iScience
1154 papers in training set
Top 1%
6.7%
50% of probability mass above
5
Molecular Therapy
81 papers in training set
Top 0.4%
4.0%
6
eLife
5828 papers in training set
Top 29%
4.0%
7
Scientific Reports
3612 papers in training set
Top 27%
4.0%
8
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.2%
2.8%
9
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 20%
2.6%
10
Journal of Biological Chemistry
690 papers in training set
Top 4%
2.4%
11
Nucleic Acids Research
1281 papers in training set
Top 8%
2.1%
12
Cell Reports
1498 papers in training set
Top 17%
2.1%
13
NAR Molecular Medicine
22 papers in training set
Top 0.2%
1.3%
14
Cell Death & Disease
126 papers in training set
Top 2%
1.3%
15
Cells
249 papers in training set
Top 7%
0.8%
16
Human Molecular Genetics
141 papers in training set
Top 3%
0.8%
17
Communications Biology
993 papers in training set
Top 30%
0.8%
18
Science Advances
1243 papers in training set
Top 30%
0.8%
19
Science Translational Medicine
127 papers in training set
Top 3%
0.8%
20
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
26 papers in training set
Top 0.9%
0.8%
21
Stem Cell Reports
130 papers in training set
Top 2%
0.6%
22
Life Science Alliance
285 papers in training set
Top 9%
0.6%